Mycobacteria inactivation using Engineered Water Nanostructures (EWNS)

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 6, 2014, Pages 1175-1183

  Pyrgiotakis, Georgios ^a   McDevitt, James ^a   Gao, Ya ^a   Branco, Alan ^a   Eleftheriadou, Mary ^b   Lemos, Bernardo ^a   Nardell, Edward ^a   Demokritou, Philip ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b EUROPEAN UNIVERSITY CYPRUS   (Cyprus)

Author keywords

Air disinfection; Engineered water Nanostructures; Lipid peroxidation; Mycobacteria; Nanoparticles

Indexed keywords

CYTOLOGY; NANOPARTICLES; NANOSTRUCTURES;

ATMOSPHERIC WATER VAPOR; ELECTROSPRAY PROCESS; ENGINEERED WATER NANOSTRUCTURES; LIPID PEROXIDATION; MYCOBACTERIA; MYCOBACTERIAL INFECTION; MYCOBACTERIUM TUBERCULOSIS; REACTIVE OXYGEN SPECIES;

CELL MEMBRANES;

ENGINEERED WATER NANOSTRUCTURE; NANOMATERIAL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; WATER; WATER VAPOR;

AEROSOL; AIR SAMPLING; AIRBORNE BACTERIUM; ARTICLE; ATMOSPHERIC MOISTURE; BACTERIA INACTIVATION; BACTERIAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSPRAY; LAMINAR FLOW; LIPID PEROXIDATION; MEMBRANE PERMEABILITY; MYCOBACTERIUM; MYCOBACTERIUM PARAFORTUITUM; NANOTECHNOLOGY; NONHUMAN; STATIC ELECTRICITY; STEADY STATE; SURFACE CHARGE; ANALYSIS; CHEMISTRY; CYTOLOGY; DEVICES; DISINFECTION; EQUIPMENT DESIGN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; OXIDATION REDUCTION REACTION; WATER VAPOR;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM PARAFORTUITUM; MYCOBACTERIUM TUBERCULOSIS;

AIR MICROBIOLOGY; DISINFECTION; EQUIPMENT DESIGN; LIPID PEROXIDATION; MYCOBACTERIUM; NANOSTRUCTURES; OXIDATION-REDUCTION; STEAM; WATER;

EID: 84905282443     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.02.016     Document Type: Article

References (43)

1. Baddeley A., Dias H.M., Falzon D., et al. Global Tuberculosis Control 2011 2011, 1-258. World Health Organization, Geneva - Switzerland. K. Floyd (Ed.).
2. Dawood F.S., Iuliano A.D., Reed C., et al. Estimated global mortality associated with the first 12months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012, 12(9):687-695.
3. Centers for Disease Control and Prevention (CDC) Trends in tuberculosis-United States, 2012. Morb Mortal Wkly Rep 2013, 62(11):201-205.
4. World Health Organization Global Tuberculosis Report (2012) 2012, 90. World Health Organization, Geneva - Switzerland. 7th ed.
5. Prazeres V., Sanchez-Sixto C., Castedo L., et al. Determination of the bound conformation of a competitive nanomolar inhibitor of Mycobacterium tuberculosis type II dehydroquinase by NMR spectroscopy. Chemmedchem 2006, 1(9):990-996.
6. Andersen B.M., Syversen G., Thoresen H., et al. Failure of dry mist of hydrogen peroxide 5% to kill Mycobacterium tuberculosis. J Hosp Infect 2010, 76(1):80-83.
7. Lai K.M., Burge H.A., First M.W. Size and UV Germicidal Irradiation Susceptibility of Serratia Marcescens When Aerosolized From Different Suspending Media. Appl Environ Microb 2004, 70(4):2021-2027.
8. Mead K., Johnson D.L. An evaluation of portable high-efficiency particulate air filtration for expedient patient isolation in epidemic and emergency response. Ann Emerg Med 2004, 44(6):635-645.
9. Chen C.Y., Wu L.C., Chen H.Y., Chung Y.C. Inactivation of Staphylococcus aureus and Escherichia coli in Water Using Photocatalysis with Fixed TiO 2. Water Air Soil Pollut 2010, 212(1):231-238.
10. Zaffina S., Camisa V., Lembo M., et al. Accidental Exposure to UV Radiation Produced by Germicidal Lamp: Case Report and Risk Assessment. Photochem Photobiol 2012, 88(4):1001-1004.
11. Clark R.P., de Calcina-Goff M.L. Some aspects of the airborne transmission of infection. J R Soc Interface 2009, 6(Suppl. 6):S767-S782.
12. Gupta S.M., Tripathi M. An overview of commonly used semiconductor nanoparticles in photocatalysis. High Energy Chem 2011, 46(1):1-9.
13. Sotiriou G.A., Diaz E., Long M.S., et al. A novel platform for pulmonary and cardiovascular toxicological characterization of inhaled engineered nanomaterials. Nanotoxicology 2011, 6(6):680-690.
14. Rao S., Shekhawat G.S. Toxicity of ZnO engineered nanoparticles and evaluation of their effect on growth, metabolism and tissue specific accumulation in Brassica juncea. J Environ Chem Eng 2014, 2(1):105-114.
15. Sotiriou G., Watson C., Murdaugh K., et al. Engineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potential. Environ Sci: Nano 2014, 1:144-153.
16. Moore T.M., Gendler E., Gendler E. Viruses adsorbed on musculoskeletal allografts are inactivated by terminal ethylene oxide disinfection. J Orthop Res 2004, 22(6):1358-1361.
17. Krause J., McDonnell G., Riedesel H. Biodecontamination of animal rooms and heat-sensitive equipment with vaporized hydrogen peroxide. Contemp Top Lab Anim Sci 2001, 40(6):18-21.
18. Klánová K., Lajèíková A. Use of Ozone to Reduce Bacteria and Moulds in the Air and on Surfaces. Indoor Built Environ 2006, 15(1):81-84.
19. Taylor R.H., Falkinham J.O., Norton C.D., LeChevallier M.W. Chlorine, chloramine, chlorine dioxide, and ozone susceptibility of Mycobacterium avium. Appl Environ Microb 2000, 66(4):1702-1705.
20. Connor A.J., Laskin J.D., Laskin D.L. Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp Mol Pathol 2012, 92(2):229-235.
21. Johnson D.F., Druce J.D., Birch C., Grayson M.L. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009, 49(2):275-277.
22. Herman P., Fauville-Dufaux M., Breyer D., et al. Biosafety Recommendations for the Contained Use of Mycobacterium tuberculosis Complex Isolates in Industrialized Countries 2006, 1-17. Scientific Institute of Public Health, Brussels - Belgium. 1st ed. P. Herman (Ed.).
23. Hall L., Otter J.A., Chewins J., Wengenack N.L. Use of Hydrogen Peroxide Vapor for Deactivation of Mycobacterium tuberculosis in a Biological Safety Cabinet and a Room. J Clin Microbiol 2007, 45(3):810-815.
24. Pyrgiotakis G., McDevitt J., Bordini A., et al. A chemical free, nanotechnology-based method for airborne bacterial inactivation using engineered water nanostructures. Environ Sci: Nano 2014, 1(1):15-26.
25. Pyrgiotakis G., McDevitt J., Yamauchi T., Demokritou P. A novel method for bacteria inactivation using Engineered Water Nanostructures. J Nanopart Res 2012, 14:1027-1038.
26. Portaels F., Silva M.T., Meyers W.M. Buruli ulcer. Clin Dermatol 2009, 27(3):291-305.
27. Gaskell S.J. Electrospray: Principles and Practice. J Mass Specrom 1997, 32:677-688.
28. Rayleigh L.F.R.S. On the Equilibrium of Liquid Conducting Masses Charged with Electricity. Philos Mag 1882, 14(87):184-186.
29. Seto T., Maekawa T., Osone S., Kawamura K., Yamauchi T., Otani Y. Formation of highly charged nanodroplets by condensation-electrospray device. Chem Eng Sci 2012, 85:46-49.
30. MaGee J.G., Ward A.C. Genus Mycobacterium. Bergy's Manual for Systematic Bacteriology 2012, Vol 5:312-375. Williams & Wilkins, Athens, GA. 2nd ed. M. Goodfellow, P. Kämpfer, H.-J. Busse (Eds.).
31. Xu P., Kujundzic E., Peccia J., et al. Impact of Environmental Factors on Efficacy of Upper-Room Air Ultraviolet Germicidal Irradiation for Inactivating Airborne Mycobacteria. Environ Sci Technol 2005, 39(24):9656-9664.
32. Peccia J., Werth H.M., Miller S., Hernandez M. Effects of Relative Humidity on the Ultraviolet Induced Inactivation of Airborne Bacteria. Aerosol Sci Tech 2001, 35(3):728-740.
33. Kujundzic E., Matalkah F., Howard C.J., Hernandez M., Miller S.L. UV air cleaners and upper-room air ultraviolet germicidal irradiation for controlling airborne bacteria and fungal spores. J Occup Environ Hyg 2006, 3(10):536-546.
34. Peccia J., Hernandez M. Photoreactivation in airborne Mycobacterium parafortuitum. Appl Environ Microb 2001, 67(9):4225-4232.
35. Demokritou P., Lee S.J., Koutrakis P. Development and Evaluation of a High Loading PM2.5 Speciation Sampler. Aerosol Sci Tech 2004, 38(2):111-119.
36. Centers for Disease Control and Prevention Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. Morb Mortal Wkly Rep 2005, 54:1-141.
37. Aliabadi A.A., Rogak S.N., Bartlett K.H., Green S.I. Preventing Airborne Disease Transmission: Review of Methods for Ventilation Design in Health Care Facilities. Adv Prev Med 2011, 2011(1-2):1-21.
38. Macher J.M. Positive-hole correction of multiple-jet impactors for collecting viable microorganisms. Am Ind Hyg Assoc J 1989, 50(11):561-568.
39. Rudnick S.N., McDevitt J.J., First M.W., Spengler J.D. Inactivating influenza viruses on surfaces using hydrogen peroxide or triethylene glycol at low vapor concentrations. Am J Infect Control 2009, 37(10):813-819.
40. Fuentes A.M., Amábile-Cuevas C.F. Antioxidant vitamins C and E affect the superoxide-mediated induction of the soxRS regulon of Escherichia coli. Microbiology (Reading, Engl) 1998, 144(7):1731-1736.
41. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6(1):130.
42. Hall-Stoodley L., Lappin-Scott H. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS Microbiol Lett 1998, 168(1):77-84.
43. Best M., Sattar S.A., Springthorpe V.S., Kennedy M.E. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol 1990, 28(10):2234-2239.